Method of preparing low-crystallinity oltipraz or amorphous oltipraz

Details for Australian Patent Application No. 2005206063 (hide)

International Classifications

Event Publications

31 August 2006 PCT application entered the National Phase

PCT publication WO2005/070397 Priority application(s): WO2005/070397

28 August 2008 Assignment before Grant

CJ Corporation The application has been assigned to CJ Cheiljedang Corporation

2 October 2008 Application Accepted

Published as AU-B-2005206063

29 January 2009 Standard Patent Sealed

29 October 2009 Assignment Registered

CJ Cheiljedang Corporation The patent has been assigned to Protherapeutics Inc.

25 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.